Safety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I Disorder
Public ClinicalTrials.gov record NCT00374920. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of MEM 1003 for the Treatment of Patients With Bipolar I Disorder Suffering Acute Manic or Mixed Episodes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to establish the potential of MEM 1003 as a safe and effective treatment for patients with an acute manic or mixed episode of bipolar disorder.
Study identification
- NCT ID
- NCT00374920
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 60 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2006 (Type not available)
- Primary completion
- Dec 2006 (Actual)
- Completion
- Mar 2007 (Actual)
- Last update posted
- May 6, 2008
2006 – 2007
United States locations
- U.S. sites
- 21
- U.S. states
- 9
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Little Rock | Arkansas | 72201 | — |
| Not listed | Garden Grove | California | 92845 | — |
| Not listed | Riverside | California | 92506 | — |
| Not listed | San Diego | California | 92105 | — |
| Not listed | Torrance | California | 90502 | — |
| Not listed | Bradenton | Florida | 34208 | — |
| Not listed | Fort Lauderdale | Florida | 33301 | — |
| Not listed | Lake Charles | Louisiana | 70601 | — |
| Not listed | Shreveport | Louisiana | 71101 | — |
| Not listed | Boston | Massachusetts | 02114 | — |
| Not listed | Willingboro | New Jersey | 08046 | — |
| Not listed | Philadelphia | Pennsylvania | 19149 | — |
| Not listed | Austin | Texas | 78729 | — |
| Not listed | Austin | Texas | 78745 | — |
| Not listed | Austin | Texas | 78756 | — |
| Not listed | Bellaire | Texas | 77401 | — |
| Not listed | Dallas | Texas | 75228 | — |
| Not listed | Houston | Texas | 77008 | — |
| Not listed | Irving | Texas | 75062 | — |
| Not listed | Kirkland | Washington | 98033 | — |
| Not listed | Kirkland | Washington | 98034 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00374920, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 6, 2008 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00374920 live on ClinicalTrials.gov.